Li Bian, Shaohua Zhang, Man Li, Jin Yang, Yongmei Yin
{"title":"在ASCENT-04中,抗体-药物偶联结合免疫治疗作为转移性三阴性乳腺癌的一线治疗方案的精确靶向细胞毒性","authors":"Li Bian, Shaohua Zhang, Man Li, Jin Yang, Yongmei Yin","doi":"10.21037/tbcr-25-32","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":101427,"journal":{"name":"Translational breast cancer research : a journal focusing on translational research in breast cancer","volume":"6 ","pages":"29"},"PeriodicalIF":1.4000,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12314681/pdf/","citationCount":"0","resultStr":"{\"title\":\"Precise targeting cytotoxicity of antibody-drug conjugate combined with immunotherapy as first-line regimen for metastatic triple-negative breast cancer in ASCENT-04.\",\"authors\":\"Li Bian, Shaohua Zhang, Man Li, Jin Yang, Yongmei Yin\",\"doi\":\"10.21037/tbcr-25-32\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":101427,\"journal\":{\"name\":\"Translational breast cancer research : a journal focusing on translational research in breast cancer\",\"volume\":\"6 \",\"pages\":\"29\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-07-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12314681/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational breast cancer research : a journal focusing on translational research in breast cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21037/tbcr-25-32\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational breast cancer research : a journal focusing on translational research in breast cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/tbcr-25-32","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
Precise targeting cytotoxicity of antibody-drug conjugate combined with immunotherapy as first-line regimen for metastatic triple-negative breast cancer in ASCENT-04.